FDA reviewing Merck's experimental insomnia drug
Thursday, November 8, 2012 - 13:00
in Health & Medicine
WHITEHOUSE STATION, N.J. (AP) -- Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its experimental insomnia medication, suvorexant (SOO'vor-eks-ant)....